Delivery Order SPE2DB22D1052-SPE2DB25FU7TP
Award Date
10/7/24
Potential Completion Date
10/8/24
Potential Value
$4.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,123.92 firm-fixed-price contract is for the delivery of 4565430340 units of the GARDASIL 9 vaccine syringe (0.5 ML). The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical for providing a comprehensive range of medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $103,322.40, is for the supply of 4,565,172,530 units of the GARDASIL 9 vaccine syringe (0.5mL). The contract has a completion date of July 18, 2024 and is a firm fixed-price contract. This award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous...
This is a delivery order contract awarded by the Medical Supply Chain division of the U.S. Department of Defense (DoD) to Amerisourcebergen Drug Corporation's Corporate Office division. The $4,958.28 firm-fixed-price contract is for the supply of 4,565,091,854 units of the GARDASIL 9 vaccine syringe, with a completion date of July 9, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies, holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,747.47, is for the procurement of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has a period of performance through March 26, 2025 and is a firm-fixed-price contract. AmerisourceBergen is an established vendor for the DLA, holding a $999,999,999 Indefinite Delivery Contract...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,765,400 units of the GARDASIL 9 SYRINGE 0.5ML vaccine, with a ceiling value of $35,173.17. The delivery order has a firm fixed price and an ultimate completion date of September 12, 2024. This contract is not set aside for any specific business...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $4,305.05 firm fixed price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of August 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a ceiling value of $24,219.51 and an ultimate completion date of August 2, 2024. The contract is a Firm Fixed Price type and has no set-aside designation. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of GARDASIL 9 vaccine syringes, with a firm fixed price of $4,997.75 and a completion date of June 12, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $9,950.72 firm-fixed-price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of August 27, 2024 and is not a set-aside award. Amerisourcebergen is a large supplier of pharmaceuticals and medical supplies to various federal agencies and healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. The delivery order has a ceiling value of $23,398.17 and a firm fixed price pricing type. The contract does not have a set-aside designation and is...